Description

Antibacterial preparation of the group of fluoroquinolones III generation.
Active against gram-positive and gram-negative microorganisms, anaerobes (including bluelegnoy bacillus), B-lactamase-producing microorganisms.

→ It is indicated for the treatment of infections of any location.

→ The double mechanism of action causes the slow development of resistance of microorganisms to the drug.

→ The drug does not inhibit the production of interferon in the body.

→ The use of the drug in therapeutic doses for 10 days does not lead to the development of candidiasis.

→ The absence of endotoxicosis in the treatment of sepsis is due to the unique mechanism of action of the drug.

→ As of 2001, 1,500,000 patients were treated with levofloxacin. These is no case of life-threatening reactions and side effects recorded.